Drilldown: Medicines
Appearance
Medicines > fda max
:
150 mg/day; therapeutic plasma-level monitoring recommended (target 50-150 ng/mL window)
or
50 mg/d
& duration:
6-12 hours 
:
150 mg/day; therapeutic plasma-level monitoring recommended (target 50-150 ng/mL window)
or
50 mg/d
& duration:
6-12 hours 
Use the filters below to narrow your results.
There are no results for this report.

